日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Downregulation of type III interferons in patients with severe COVID-19.

重症 COVID-19 患者体内 III 型干扰素表达下调

Fukuda Yosuke, Homma Tetsuya, Inoue Hideki, Onitsuka Chisato, Ikeda Hitoshi, Goto Yuiko, Sato Yoko, Kimura Tomoyuki, Hirai Kuniaki, Ohta Shin, Yamamoto Mayumi, Kusumoto Sojiro, Suzuki Shintaro, Tanaka Akihiko, Sagara Hironori

Extracorporeal Membrane Oxygenation for Secondary Organizing Pneumonia after Severe SARS-CoV-2 Infection: A Case Report

体外膜肺氧合治疗重症SARS-CoV-2感染后继发性机化性肺炎:病例报告

Kimura, Tomoyuki; Onitsuka, Chisato; Kawahara, Tomoko; Fukuda, Yosuke; Homma, Tetsuya; Watanabe, Taro; Ohsugi, Koichi; Ichikawa, Yuki; Shono, Atsuko; Kotani, Toru; Sagara, Hironori

Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD

在一例合并慢性阻塞性肺疾病的重症新冠肺炎患者中,采用短期全身性糖皮质激素联合法匹拉韦治疗取得了成功。

Inoue, Hideki; Jinno, Megumi; Ohta, Shin; Kishino, Yasunari; Kawahara, Tomoko; Mikuni, Hatsuko; Sato, Haruna; Yamamoto, Mayumi; Sato, Yoko; Onitsuka, Chisato; Goto, Yuiko; Ikeda, Hitoshi; Sato, Hiroki; Uno, Tomoki; Uchida, Yoshitaka; Kimura, Tomoyuki; Miyata, Yoshito; Hirai, Kuniaki; Homma, Tetsuya; Watanabe, Yoshio; Kusumoto, Sojiro; Suzuki, Shintaro; Tokimatsu, Issei; Tanaka, Akihiko; Sagara, Hironori